secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocugen, Inc. (OCGN)
CIK:        0001372299
Form:       8-K
Filed at:   2026-06-11T21:19:26+00:00
Accession:  0001104659-26-073015
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocugen appoints Mohamed Genead as permanent Chief Medical Officer; shareholders elect directors and approve say-on-pay
--------------------------------------------------------------------------------

- Mohamed Genead, M.D., M.Sc., appointed Chief Medical Officer effective June 11, 2026; had served as Acting/Interim CMO since May 8, 2026.
- Shareholders elected Kirsten Castillo and Satish Chandran as Class III directors for terms expiring in 2029.
- Say-on-pay advisory vote approved: 49,968,948 votes for, 13,245,090 against, 1,505,123 abstentions.
- Shareholders preferred a one-year frequency for future say-on-pay votes; Board adopted that frequency.
- Ratification of PwC as independent auditor for fiscal 2026 passed with 136,784,245 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/0001104659-26-073015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372299/000110465926073015/tm2617722d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer